Patent · US Active

Identification of surface-associated antigens for tumor diagnosis and therapy

US10302647B2 · kind B2 · utility

0Cited by

2References

8Claims

0Family size

Assignee

BioNTech AG · DE

Inventors

Ugur Sahin · Mainz, DE
Ozlem Tureci · Homburg, DE
Michael Koslowski · Mainz, DE
Gerd Helftenbein · Mücke, DE
Dirk Usener · Wiesbaden, DE
Volker Schlüter · Schwanau, DE

Key dates

Filing date	Mar 7, 2016
Grant date	May 28, 2019
Priority date	—
Expiry date	Apr 29, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/158
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The invention relates to identifying tumor-associated genetic products and encoding nucleic acids thereof. A therapy and diagnosis of diseases in which the tumor-associated genetic products are aberrantly expressed, proteins, polypeptides and peptides which are expressed in association with tumor and the encoding nucleic acids for said proteins, polypeptides and peptides are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.